Unimad Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 26-05-2024
- Paid Up Capital ₹ 0.30 M
as on 26-05-2024
- Company Age 41 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 70.00 K
as on 26-05-2024
- Revenue %
(FY 2020)
- Ebitda
- Net Worth -233.99%
(FY 2020)
- Total Assets -47.43%
(FY 2020)
About Unimad Pharmaceuticals
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹70,000.00.
Ujagar Singh, Babar Kailay, Jagjit Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232PB1983PTC005268
- Company No.
005268
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Jan 1983
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unimad Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujagar Singh  | Director | 12-Jun-1991 | Current |
| Babar Kailay | Director | Current | |
| Jagjit Singh | Director | 12-Jun-1991 | Current |
| Jitender Singh | Director | 20-Apr-1992 | Current |
Financial Performance of Unimad Pharmaceuticals.
Unimad Pharmaceuticals Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 233.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Unimad Pharmaceuticals?
In 2017, Unimad Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Patiala Creation Date: 30 Jul 1983 | ₹0.07 M | Open |
How Many Employees Work at Unimad Pharmaceuticals?
Unlock and access historical data on people associated with Unimad Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unimad Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unimad Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
